Returns Chart

Key Stats

Customize
Expense Ratio Total Assets Under Management Dividend Yield Turnover Ratio
1.27% 228.49M 0.00% 87.73%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized All Time Total Returns (Daily) Max Drawdown (All)
41.31M -12.00% Upgrade Upgrade

Basic Info

Investment Strategy
The fund seeks to obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies.
General
Security Type Mutual Fund
Oldest Share Symbol ATL1027
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Global Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name CIBC Asset Management Inc
Prospectus Benchmark Index
MSCI World/Information Tech NR USD 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Jonathan Mzengeza 4.76 yrs
Michal Marszal 4.48 yrs
Craig Jerusalim 2.68 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 31
41.31M
-592.74M Category Low
6.342B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of December 31, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of January 26, 2022. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
31.97%
-2.17%
32.68%
8.54%
36.36%
48.66%
4.36%
-13.01%
-7.76%
21.36%
9.78%
-7.58%
21.93%
5.56%
28.04%
-2.49%
20.38%
1.72%
14.15%
5.31%
28.06%
23.16%
19.33%
-7.69%
--
--
--
-0.59%
18.79%
17.74%
14.62%
-9.59%
--
--
--
--
--
--
4.29%
-12.90%
--
--
--
--
--
--
11.92%
-14.39%
As of January 26, 2022.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (1-26-22) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 0.0332
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 31, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 31, 2021

Asset Allocation

As of December 31, 2021.
Type % Net % Long % Short
Cash 1.48% Upgrade Upgrade
Stock 98.68% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other -0.16% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Microsoft Corp 8.58% 296.71 2.85%
Alphabet Inc Class A 7.60% 2584.66 1.81%
Takeda Pharmaceutical Co Ltd
5.88% -- --
CVS Health Corp 5.32% 104.86 1.71%
IQVIA Holdings Inc 4.57% 232.64 -1.52%
Ascendis Pharma A/S ADR 4.39% 116.16 2.27%
Sarepta Therapeutics Inc 4.19% 70.24 2.23%
Alcon Inc
3.97% -- --
Tencent Holdings Ltd ADR 3.62% 59.43 -1.11%
ASML Holding NV
3.51% -- --

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee Upgrade
Administration Fee --
Performance Fee --
Switching Fee Upgrade
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP Yes
Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The fund seeks to obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies.
General
Security Type Mutual Fund
Oldest Share Symbol ATL1027
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Global Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name CIBC Asset Management Inc
Prospectus Benchmark Index
MSCI World/Information Tech NR USD 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Jonathan Mzengeza 4.76 yrs
Michal Marszal 4.48 yrs
Craig Jerusalim 2.68 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (1-26-22) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 0.0332
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 31, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 31, 2021

Fund Details

Key Dates
Inception Date 12/14/2000
Last Annual Report Date 8/31/2021
Last Prospectus Date --
Share Classes
ATL1027 Commission-based Advice
ATL1227 --
ATL1637 --
ATL1745 Institutional
ATL6737 --
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0